Home » Stocks » AVNS

Avanos Medical, Inc. (AVNS)

Stock Price: $39.79 USD -0.18 (-0.45%)
Updated Jun 16, 2021 10:12 AM EDT - Market open
Market Cap 1.92B
Revenue (ttm) 715.10M
Net Income (ttm) -38.50M
Shares Out 47.97M
EPS (ttm) -0.81
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day June 16
Last Price $39.79
Previous Close $39.97
Change ($) -0.18
Change (%) -0.45%
Day's Open 39.94
Day's Range 39.79 - 40.18
Day's Volume 28,798
52-Week Range 27.09 - 53.61

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

Investors continue to be optimistic about Avanos (AVNS), owing to its strong product line and focus on its R&D.

3 weeks ago - Zacks Investment Research

NEW YORK, May 10, 2021 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600: S&P MidCap 400 constituent Charles River Laboratories I...

Other stocks mentioned: CRL, EFC, NSA, SPGI, TDY
1 month ago - PRNewsWire

Avanos Medical (AVNS) continues to gain from its core Chronic Care segment in the first quarter.

1 month ago - Zacks Investment Research

Avanos Medical (AVNS) delivered earnings and revenue surprises of 27.78% and 2.30%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

ALPHARETTA, Ga., May 7, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported first quarter 2021 financial results.

1 month ago - PRNewsWire

ALPHARETTA, Ga., April 30, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the first quarter 2021 on Frid...

1 month ago - PRNewsWire

Avanos Medical (AVNS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago - Zacks Investment Research

Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock?

2 months ago - Zacks Investment Research

ALPHARETTA, Ga., March 16, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Joe Woody, chief executive officer, will present at the Virtual KeyBanc Life Sciences & MedTech Inv...

3 months ago - PRNewsWire

Investor confidence is high in Avanos Medical (AVNS) stock, courtesy of its solid prospects.

3 months ago - Zacks Investment Research

ALPHARETTA, Ga., Feb. 24, 2021 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, senior vice president and chief financial officer, will present at the Virtual Raym...

3 months ago - PRNewsWire

Avanos Medical (AVNS) continues to gain from its core Chronic Care segment in the fourth quarter.

3 months ago - Zacks Investment Research

Avanos Medical (AVNS) delivered earnings and revenue surprises of 27.27% and 0.67%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

Shares of Avanos Medical (NYSE:AVNS) rose 0.1% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share were down 17.65% year over year to $0.28, which beat the ...

3 months ago - Benzinga

Investor confidence is high on Avanos Medical (AVNS), courtesy of solid prospects.

5 months ago - Zacks Investment Research

Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock?

6 months ago - Zacks Investment Research

ALPHARETTA, Ga., Nov. 5, 2020 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that it would present at the following two virtual investor conferences in November: Conference: Stifel 20...

7 months ago - PRNewsWire

Avanos Medical (AVNS) continued to gain from core Chronic Care segment in the third quarter.

7 months ago - Zacks Investment Research

Avanos Medical's (AVNS) CEO Joe Woody on Q3 2020 Results - Earnings Call Transcript

7 months ago - Seeking Alpha

Avanos Medical (AVNS) delivered earnings and revenue surprises of 50.00% and 11.94%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

7 months ago - Zacks Investment Research

ALPHARETTA, Ga., Nov. 3, 2020 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported third quarter 2020 financial results. "Thanks to the work of our team and their focus on execution, our mom...

7 months ago - PRNewsWire

ALPHARETTA, Ga., Oct. 27, 2020 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the third quarter 2020 on Tuesd...

7 months ago - PRNewsWire

Investor confidence is high on Avanos Medical (AVNS), thanks to solid prospects.

8 months ago - Zacks Investment Research

ALPHARETTA, Ga., Sept. 15, 2020 /PRNewswire/ -- Avanos Medical, Inc.

9 months ago - PRNewsWire

ALPHARETTA, Ga., Sept. 4, 2020 /PRNewswire/ -- Avanos Medical, Inc.

9 months ago - PRNewsWire

Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock?

9 months ago - Zacks Investment Research

ALPHARETTA, Ga., Sept. 3, 2020 /PRNewswire/ -- Avanos Medical, Inc.

9 months ago - PRNewsWire

ALPHARETTA, Ga., Aug. 31, 2020 /PRNewswire/ -- Avanos Medical, Inc.

9 months ago - PRNewsWire

Avanos Medical's (AVNS) second-quarter results benefit from contribution from Chronic Care segment.

10 months ago - Zacks Investment Research

Avanos Medical, Inc. (AVNS) CEO Joe Woody on Q2 2020 Results - Earnings Call Transcript

10 months ago - Seeking Alpha

Avanos Medical (AVNS) delivered earnings and revenue surprises of 262.50% and 10.19%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

10 months ago - Zacks Investment Research

ALPHARETTA, Ga., Aug. 4, 2020 /PRNewswire/ -- Avanos Medical, Inc.

10 months ago - PRNewsWire

Avanos Medical (AVNS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

10 months ago - Zacks Investment Research

Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock?

1 year ago - Zacks Investment Research

ALPHARETTA, Ga., May 28, 2020 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that it would present at the following two virtual investor conferences in June: Conference: Jefferies Vir...

1 year ago - PRNewsWire

Avanos Medical, Inc. (AVNS) CEO Joe Woody on Q1 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Avanos Medical's (AVNS) first-quarter results benefit from segmental contribution.

1 year ago - Zacks Investment Research

Avanos Medical (AVNS) delivered earnings and revenue surprises of -5.88% and 4.04%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

Avanos Medical (AVNS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 year ago - Zacks Investment Research

Avanos Medical (AVNS) continues to benefit from strong performing segments and robust product portfolio. However, weak performance at Acute Pain unit raises concern.

1 year ago - Zacks Investment Research

Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock?

1 year ago - Zacks Investment Research

Avanos (AVNS) gains from solid fourth-quarter show despite headwinds in the Acute Pain business.

1 year ago - Zacks Investment Research

Avanos (AVNS) gains from segmental contributions in Q4.

1 year ago - Zacks Investment Research

Avanos Medical, Inc. (AVNS) CEO Joe Woody on Q4 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Avanos Medical (AVNS) delivered earnings and revenue surprises of 6.25% and 6.73%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock?

1 year ago - Zacks Investment Research

Avanos (AVNS) third-quarter results benefit from higher revenues and strong segmental performance.

1 year ago - Zacks Investment Research

Avanos Medical, Inc. (AVNS) CEO Joe Woody on Q3 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Shares slump after the company reports weak third-quarter results and cuts guidance. Here's what investors need to know.

1 year ago - The Motley Fool

Avanos Medical (AVNS) delivered earnings and revenue surprises of -6.25% and -5.11%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

1 year ago - Zacks Investment Research

About AVNS

Avanos Medical, Inc. operates as a medical technology company that focuses on delivering medical device solutions to improve patients' quality of life in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management... [Read more...]

Industry
Medical Devices
CEO
Joseph Woody
Employees
5,380
Stock Exchange
NYSE
Ticker Symbol
AVNS
Full Company Profile

Financial Performance

In 2020, Avanos Medical's revenue was $714.80 million, an increase of 2.47% compared to the previous year's $697.60 million. Losses were -$27.20 million, -40.74% less than in 2019.

Financial Statements

Analyst Forecasts

According to 7 analysts, the average rating for Avanos Medical stock is "Buy." The 12-month stock price forecast is 51.00, which is an increase of 28.17% from the latest price.

Price Target
$51.00
(28.17% upside)
Analyst Consensus: Buy